SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001860782-23-000112
Filing Date
2023-11-14
Accepted
2023-11-14 07:02:36
Documents
16
Period of Report
2023-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tvst-20231114.htm   iXBRL 8-K 30384
2 EX-99.1 q32023earningspr_final.htm EX-99.1 65206
6 image_0a.jpg GRAPHIC 48735
7 image_1a.jpg GRAPHIC 623235
8 image_2a.jpg GRAPHIC 32722
  Complete submission text file 0001860782-23-000112.txt   1212781

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvst-20231114.xsd EX-101.SCH 2010
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvst-20231114_lab.xml EX-101.LAB 24833
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvst-20231114_pre.xml EX-101.PRE 13144
10 EXTRACTED XBRL INSTANCE DOCUMENT tvst-20231114_htm.xml XML 2808
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

IRS No.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40791 | Film No.: 231401529
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences